» Articles » PMID: 25496311

A Phospholipid Complex to Improve the Oral Bioavailability of Flavonoids

Overview
Publisher Informa Healthcare
Specialty Pharmacology
Date 2014 Dec 16
PMID 25496311
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: A phospholipid complex (TFH-PC) was prepared to increase the oral bioavailability of isorhamnetin, kaempferol, and quercetin from TFH (total flavones of Hippophae rhamnoides L.).

Methods: Solvent evaporation was used to prepare TFH-PC. Relevant parameters were investigated based on the complexation rate of isorhamnetin, kaempferol, and quercetin. Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), X-ray power diffraction (X-RPD), and scanning electron microscopy (SEM) were used for characterization. Solubility, octanol-water partition coefficient (log P), dissolution rate, and in vivo pharmacokinetics were also investigated.

Results: TFH-PC was successfully prepared in tetrahydrofuran with a drug to phospholipid ratio of 1:1, reaction temperature of 20 °C, and a reaction time of 1 h. The complexation rates of isorhamnetin, kaempferol, and quercetin were 97.7%, 95.97%, and 92.23%, respectively. FT-IR, DSC, X-RPD, and SEM confirmed the formation of TFH-PC. The aqueous solubilities of the three flavonoids in TFH-PC increased 22.0-26.8-fold compared with TFH. The dissolution of isorhamnetin, kaempferol, and quercetin in TFH-PC was 84.32%, 90.77%, and 100% within 10 min, respectively, greatly improved over TFH. After oral administration of TFH-PC in rats, the bioavailability of isorhamnetin, kaempferol, and quercetin in TFH-PC relative to TFH was 223%, 172%, and 242%, respectively.

Conclusion: The oral absorption of isorhamnetin, kaempferol, and quercetin was significantly improved in TFH-PC, mainly due to increased solubility and dissolution rate. This phospholipid complex shows potential for oral delivery of the flavonoids in TFH.

Citing Articles

Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review).

Ding Y, Yu Y Mol Med Rep. 2025; 31(4).

PMID: 40017144 PMC: 11884236. DOI: 10.3892/mmr.2025.13474.


Docking and Molecular Dynamics Studies on Anticancer Activities of Flavonoids as Inhibitors of CDK2 and CDK9.

Sony A, Suresh M Med Chem. 2025; 21(1):69-83.

PMID: 39916437 DOI: 10.2174/0115734064314933240812120123.


Enhanced absorption of prenylated cinnamic acid derivatives from Brazilian green propolis by turmeric in humans and rats.

Yamaga M, Kawabe H, Tani H, Yamaki A Food Sci Nutr. 2024; 12(7):4680-4691.

PMID: 39055207 PMC: 11266932. DOI: 10.1002/fsn3.4116.


Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders.

Toma L, Deleanu M, Sanda G, Barbalata T, Niculescu L, Sima A Int J Mol Sci. 2024; 25(8).

PMID: 38673748 PMC: 11049841. DOI: 10.3390/ijms25084162.


Solvent Free Twin Screw Processed Silybin Nanophytophospholipid: In Silico, In Vitro and In Vivo Insights.

Fernandes G, Pusuluri S, Nikam A, Birangal S, Shenoy G, Mutalik S Pharmaceutics. 2022; 14(12).

PMID: 36559222 PMC: 9782009. DOI: 10.3390/pharmaceutics14122729.